Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2776 of 5804
-
Experimental cancer combo targets Hard-to-Treat tumours
Disease control OngoingThis is a Phase 1, open-label study of ceralasertib given in combination with durvalumab in Chinese participants with advanced solid tumours. In each cohort, a monotherapy lead-in period (Cycle 0, duration of 7 or 14 days), prior to dosing with durvalumab, is added to investigate…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
VR goggles ease needle pain for allergic kids
Symptom relief CompletedMain objective : Evaluate the effect of using a virtual reality mask during the blood test and pricks tests in allergic children aged from 7 to 13 years. Hypothesis : Using virtual reality mask during blood test and pricks tests for allergic kids from 7 to 13 would reduce anxi…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Spinal device eases diabetic nerve pain in small study
Symptom relief CompletedThe purpose of the study is to evaluate the effects of stimulation parameters on clinical outcomes of Spinal Cord Stimulation (SCS) in the treatment of chronic, intractable limb pain resulting from painful Diabetic Peripheral Neuropathy (pDPN).
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Could morning light soothe your gut? new trial tests bright light therapy for Crohn's
Symptom relief Recruiting nowCrohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the most significant chronic conditions of the gastrointestinal tract (GIT) and affects over 1.5 million individuals in the U.S. Recently, there has been an increa…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can talking therapy cut alcohol use and save lives in TB and HIV patients?
Disease control OngoingThe highest incidence of tuberculosis disease (TB) in the world is in India, accounting for 27% of all new cases globally, with approximately 86,000 among persons with HIV (PWH). Unhealthy alcohol use can worsen the health of people who have Tuberculosis (TB), HIV and people who …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for diabetic nerve pain: platform trial tests multiple treatments
Symptom relief CompletedThis is a Platform Protocol to perform Phase II clinical trials in The Early Phase Pain Investigation Clinical Network (EPPIC-Net), under The Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, related to the treatment of Painful Diabetic Peripheral Neuropa…
Phase: PHASE2 • Sponsor: James P. Rathmell, MD • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Pre-Surgery video slashes opioid use after joint replacement?
Symptom relief OngoingOne of the most challenging issues in modern medicine is the current opioid epidemic. Given the association between opioid use after surgery and the development of opioid addiction, an essential goal of the medical community should be to develop strategies aimed at instructing th…
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can a virtual boot camp help Parkinson's patients stay steady?
Symptom relief Recruiting nowThis project will determine the feasibility and efficacy of remote assessment and treatment of balance disorders in people with Parkinson's disease.
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Brain scan study aims to spot tau protein in rare dementias
Knowledge-focused Recruiting nowThe investigators will compare \[18F\]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal subjects.
Phase: PHASE3 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Could a common antibiotic shrink NF2 skin tumors without surgery?
Disease control OngoingIn this research study the investigators want to learn more about an alternate, local treatment for skin schwannomas. Specifically, local doxycycline intra-tumoral injection will be performed as a potential treatment for NF2-related skin schwannomas, ultimately reducing the risks…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New device aims to improve liver transplant outcomes
Disease control OngoingTo provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial
Phase: NA • Sponsor: Organ Recovery Systems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New chemo mist targets abdominal cancer with fewer side effects
Disease control TerminatedThis phase I trial studies the side effects of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel in combination with gemcitabine and cisplatin in treating patients with biliary tract cancer that has spread to the peritoneum (peritoneal metastases). PIPAC…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Ear-Zap therapy could spare kids from harsh kidney drugs
Disease control Recruiting nowChildren with steroid resistant nephrotic syndrome (SRNS) are exposed to prolonged courses of immunosuppressant medications. Given the adverse side effect profiles and variable efficacy of these medications, there is an urgent need to identify novel and safe therapies to treat ne…
Phase: NA • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Talking yourself out of cravings: brain scans reveal how Self-Talk may rewire food addiction
Knowledge-focused CompletedWhy in some situations can words soothe our cravings? This research proposal will test the power of self-generated reasons for behavioural change in food addiction, which concerns about three out of ten persons and causes major life hazards such as obesity, diabetes and cancer. W…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
School Stress-Busting program for LGBTQ teens shows promise, but study cut short
Symptom relief TerminatedEfficacy of a Multi-level School Intervention for LGBTQ Youth
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New device hunts for wandering cancer cells to predict relapse
Knowledge-focused Recruiting nowThe GILUPI CellCollector® is the first in vivo CTC isolation product worldwide, which is CE approved. This is a prospective, multicenter study to evaluate the prognostic value of circulating tumor cells in breast cancer patients who completed surgery after neoadjuvant treatment.
Phase: NA • Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Blood cancer Patients' vaccine response under the microscope
Knowledge-focused Recruiting nowBackground: People with B cell malignancies (blood cancers) often cannot mount a full immune response to infections or certain vaccines. Bruton tyrosine kinase inhibitors (BTKis), which are used to treat blood cancers, may also negatively affect a person s response to certain va…
Phase: PHASE4 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Needle-Free myeloma monitoring: blood test and MRI show promise
Knowledge-focused CompletedThe purpose of this study is to investigate the sensitivity and accuracy of non-invasive MRD assessment using liquid biopsy (blood draw) and functional imaging (whole body MRI) in participants with new diagnosed and previously treated multiple myeloma. The long-term goal of this …
Sponsor: Rajshekhar Chakraborty, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Mystery chest pain: study digs deeper to find hidden heart problems
Knowledge-focused OngoingThe overall objective of this multi-center registry is to identify specific phenotypes of INOCA with both an anatomic evaluation (coronary angiography and intravascular imaging) and physiologic assessment with the Abbott Coroventis Coroflow Cardiovascular System, and to determine…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Can stem cell molecules rebuild wasted muscles? new trial aims to find out
Disease control Recruiting nowAn open-label dose escalation study to assess the safety and tolerability of IMM01-STEM in participants with muscle atrophy related to knee osteoarthritis
Phase: PHASE1, PHASE2 • Sponsor: Immunis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC